Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Fenfluramine for treatment-resistant epilepsy in Dravet syndrome and other genetically mediated epilepsies.

Improving early diagnosis of rare diseases using Natural Language Processing in unstructured medical records: an illustration from Dravet syndrome.

Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown.

Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome.

Genetics Analysis of patients with Dravet syndrome due to mosaicism variation of paternal SCN1A gene.

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.

The impact of COVID-19 in Dravet syndrome: A UK survey.

Analysis of SCN1A gene variants among patients with Dravet syndrome.

Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea.

Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.

Fenfluramine HCl (Fintepla® ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study.

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.

Showing 1-12 of 40